Richmond Investment Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,234
Closed -$486K 146
2026
Q1
$486K Buy
2,234
+191
+9% +$42.4K 0.08% 161
2025
Q4
$467K Buy
2,043
+274
+15% +$62.4K 0.08% 147
2025
Q3
$410K Buy
1,769
+244
+16% +$49.7K 0.08% 155
2025
Q2
$283K Buy
+1,525
New +$283K 0.06% 169

Other funds holding ABBV

Richmond Investment Services's ABBV Position: Q2 2026 in Review

Richmond Investment Services sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 2,234 shares — an estimated $486K sold.

Richmond Investment Services first reported a position in ABBV in Q2 2025 and held it in 4 quarters. The position peaked at $486K in Q1 2026. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Richmond Investment Services reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Richmond Investment Services sold 2,234 AbbVie shares in Q2 2026, an estimated $486K.
  • Richmond Investment Services first reported a position in AbbVie in Q2 2025 and held it in 4 quarters.
  • Richmond Investment Services's AbbVie position peaked at $486K in Q1 2026.
  • 4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Richmond Investment Services's 13F filing for Q2 2026, filed 27 Jul 2026.